Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00006465 · ClinicalTrials.gov registry record · Phase 1

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

A Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
Phase 1
Development phase
22
Enrollment target
1
Study location

NCT00006465 is a Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 22 participants, below the 501-participant average among 83 other Unspecified Adult Solid Tumor, Protocol Specific trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00006465, a Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
Phase 1
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy in treating patients who have advanced solid tumors.

Conditions Studied

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

  • DRUG oxaliplatin
  • DRUG capecitabine
  • DRUG irinotecan hydrochloride

Study Locations (1)

Ohio

  • Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center - Cleveland

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2000-12
Est. Completion 2005-04
Phase Phase 1

Sponsor

Case Comprehensive Cancer Center

407 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00006465

The ClinicalTrials.gov registry entry for NCT00006465 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 501-participant average among 83 other Unspecified Adult Solid Tumor, Protocol Specific trials with a reported enrollment target (96% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Unspecified Adult Solid Tumor, Protocol Specific appearing as the primary indexed condition, and to 3 interventions - of which oxaliplatin is the first listed.

NCT00006465 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00006465 about?

NCT00006465 is a clinical study titled "Combination Chemotherapy in Treating Patients With Advanced Solid Tumors". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy in treating patients who have advanced solid ...

What is the current status of trial NCT00006465?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2000-12. Estimated completion is 2005-04.

What conditions does trial NCT00006465 study?

This clinical trial studies the following conditions: Unspecified Adult Solid Tumor, Protocol Specific.

What interventions are being tested in trial NCT00006465?

The interventions under investigation include: oxaliplatin (DRUG), capecitabine (DRUG), irinotecan hydrochloride (DRUG).

Who is sponsoring clinical trial NCT00006465?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00006465 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Unspecified Adult Solid Tumor, Protocol Specific

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Unspecified Adult Solid Tumor, Protocol Specific

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.